Table 4 Subgroup analysis of the association between VFA-to-LMM ratio and hyperuricemia according to menopausal status
Menopausal status | Model 1a | Model 2 | Model 3 | Model 4 |
|---|---|---|---|---|
Pre-menopausal | ||||
 Quartile 1 | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) |
 Quartile 2 | 3.50 (1.06, 15.75) | 3.65 (1.10, 16.47) | 3.63 (1.04, 17.10) | 2.78 (0.79, 13.06) |
 Quartile 3 | 5.01 (1.61, 21.95) | 5.30 (1.70, 23.27) | 4.62 (1.36, 21.65) | 2.84 (0.78, 13.74) |
 Quartile 4 | 12.04 (4.21, 50.78) | 12.97 (4.50, 54.99) | 8.25 (2.52, 37.99) | 3.61 (0.90, 18.86) |
 P for trendb | < .0001 | < .0001 | 0.0005 | 0.1503 |
Post-menopausal | ||||
 Quartile 1 | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) |
 Quartile 2 | 2.52 (1.29, 5.19) | 2.50 (1.27, 5.18) | 2.18 (1.05, 4.73) | 1.79 (0.84, 3.96) |
 Quartile 3 | 2.36 (1.20, 4.89) | 2.25 (1.14, 4.69) | 1.85 (0.88, 4.03) | 1.35 (0.61, 3.09) |
 Quartile 4 | 3.71 (1.95, 7.51) | 3.43 (1.79, 6.99) | 3.33 (1.64, 7.13) | 1.94 (0.80, 4.81) |
 P for trend | 0.0003 | 0.0010 | 0.0029 | 0.3130 |